Syros Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Syros Pharmaceuticals Inc
TickerSYRS
CIK #0001556263
CUSIP87184Q107
SectorLife Sciences - Pharmaceutical Preparations
Address480 Arsenal Street Suite 130, Watertown, MA 02472
Source [EDGAR]
CIK Filing 2011 - 2024
[0001556263] 10-K
[0001556263] 10-Q
[0001556263] 3
[0001556263] 4
[0001556263] 5
[0001556263] 8-K
[0001556263] D
[0001556263] SC 13D
[0001556263] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Adage Capital Partners GP LLC Syros Pharmaceuticals Inc [2023-01-25] 6.04
Avidity Partners Management LP Syros Pharmaceuticals Inc [2022-09-20] 0.9
Deep Track Capital LP Syros Pharmaceuticals Inc [2022-09-19] 0.99
Syros Pharmaceuticals Inc TYME Technologies Inc [2022-07-13] 0.9
TYME Technologies Inc Syros Pharmaceuticals Inc [2022-07-13] 28.0
BlackRock Inc Syros Pharmaceuticals Inc [2022-07-08] 2.4
Artal International SCA Syros Pharmaceuticals Inc [2022-02-11] 5.6
Ally Bridge Medalpha Master Fund LP Syros Pharmaceuticals Inc [2020-12-18] 5.4
Bain Capital Life Sciences Fund II LP Syros Pharmaceuticals Inc [2020-12-14] 9.99
Point72 Asset Management LP Syros Pharmaceuticals Inc [2020-04-02] 5.1
BlackRock Inc Syros Pharmaceuticals Inc [2020-02-07] 6.7
Sumitomo Mitsui Trust Holdings Inc Syros Pharmaceuticals Inc [2019-09-09] 10.15
Nikko Asset Management Americas Inc Syros Pharmaceuticals Inc [2019-09-06] 10.15
Flynn James E Syros Pharmaceuticals Inc [2019-04-09] 0.9
ARK Investment Management LLC Syros Pharmaceuticals Inc [2019-02-14] 7.31
BlackRock Inc Syros Pharmaceuticals Inc [2019-02-08] 5.9
Polaris Partners VII LP Syros Pharmaceuticals Inc [2016-07-14] 6.8
Flagship Ventures Fund IV General Partner LLC Syros Pharmaceuticals Inc [2016-07-11] 20.6
FMR LLC Syros Pharmaceuticals Inc [2016-07-11] 0.0
Flynn James E Syros Pharmaceuticals Inc [2016-07-06] 2.69
Form 3/4/5 Filer 2011 - 2024
Syros Pharmaceuticals, Inc.
Akkaraju Srinivas
Young Richard A
Wirth Peter
Tyson Timothy
OH Andrew M
Fanucci Marsha
Eckhardt Sue Gail
Dunsire Deborah
Alles Mark J
Olson Eric R
Haas Jason
Chee Conley
Roth David
Stephens Kristin
Simonian Nancy A
Quirk Gerald E
Sharp Phillip A
Nashat Amir
Springhorn Jeremy P.
Ferra Joseph J Jr
ARCH Venture Partners VII, LLC
ARCH Venture Fund VII, L.P.
Crandell Keith
ARCH Venture Partners VII, L.P.
Nelsen Robert
Bybee Clinton
Shaw Alice Tsang
Sato Vicki L
Bonney Michael W
Afeyan Noubar
DeSimone Colleen Elizabeth
Flagship Ventures Fund IV-Rx, L.P.
Flagship VentureLabs IV, LLC
Flagship Ventures Fund IV, L.P.
Flagship Ventures Fund IV General Partner LLC
Kania Edwin M Jr
Patel Sanj K
Bancel Stephane
Green Jeremy
Redmile Group, LLC
Polaris Entrepreneurs' Fund VII, L.P.
Polaris Partners VII, L.P.
Polaris Management Co. VII, L.L.C.
WuXi PharmaTech Healthcare Fund I L.P.
Flynn James E
Deerfield Mgmt L.P.
Deerfield Management Company LP Series C
Deerfield Mgmt III, L.P.
Deerfield Special Situations Fund, L.P.
Deerfield Private Design Fund III, L.P.
Aisling Capital Partners III LLC
Aisling Capital Partners III LP
Elms Steve
Schiff Andrew N
Aisling Capital III LP
Purcell Dennis J
WuXi Healthcare Ventures II, L.P.
JEB Syros Trust
Perspecta Trust LLC
Conde Jorge
Gray Nathanael
Kuvalanka Kyle D.
Form 13F Holdings
Firm Period DFND Voting Shares
Ten Capital Wealth Advisors LLC [2023-03-31] SOLE 219.0 219.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com